Skip to main content
MJH Life Sciences
  • Login
  • Register
  • Login
  • Register
Home
  • Topics
  • Slideshows
  • Videos
  • Quizzes
  • Blogs
  • Conferences
  • Classifieds
  • All Content
  • Contribute
MJH Life Sciences

SUBSCRIBE: eNewsletter

New Therapeutic Options

An expert discusses the options available to help improve tolerance and adherence challenges that clinicians commonly face in epilepsy practice.

Recent Content

Exploring Alternative AED Dosing to Boost Treatment Adherence

September 12, 2019
  • Alicia Bigica

Rodney Allan Radtke, MD, professor of neurology at Duke University School of Medicine in Durham, North Carolina, discussed some of the new therapeutic options available to help improve tolerance and adherence challenges that clinicians commonly face in epilepsy practice.

AAN Releases Multiple Sclerosis Vaccination Guidelines

September 10, 2019
  • Matt Hoffman

The guidelines recommend that patients with MS receive their recommended vaccines, including that for yearly influenza. Additionally, they noted that no evidence exists that suggests vaccination increases the risk of MS exacerbation.

Using the Ketogenic Diet to Treat Intractable Epilepsy in a Case of Glycine Encephalopathy

September 9, 2019
  • Lauryn Currens, MD

A boy diagnosed with glycine encephalopathy in the newborn period was initiated on the ketogenic diet at 11 years-old for the treatment of medication refractory epilepsy.

Istradefylline Approved for Parkinson Add-On Therapy

September 6, 2019
  • Matt Hoffman

After being approved in Japan in 2013, the selective adenosine A 2A receptor antagonist was given the OK as an add-on to levodopa/carbidopa treatment in adults with Parkinson disease.

Migraine brain head pain headache

Fremanezumab Effective in Refractory Episodic and Chronic Migraine

August 23, 2019
  • Alicia Bigica

Data from the phase 3b FOCUS trial demonstrates fremanezumab’s superior efficacy and tolerability in the prevention of migraine.

Alzheimer disease

Podcast: Is Amyloid Really Dead?

August 23, 2019
  • Alicia Bigica

"Mind Moments," a podcast from NeurologyLive, brings you an exclusive interview with Reisa Sperling, MD.

Pitolisant Offers Important Risk-Benefit Profile for Patients With Narcolepsy

August 23, 2019
  • Matt Hoffman

Jeffrey Dayno, MD, chief medical officer of Harmony Biosciences, as well as John C. Jacobs, the chairman and CEO, shared their insight into the potential impact pitolisant can make in the treatment of narcolepsy and excessive daytime sleepiness.

FDA

FDA Rejects Duchenne Muscular Dystrophy Drug Golodirsen, Citing Safety Concerns

August 23, 2019
  • Jenna Payesko

The regulatory agency cited 2 concerns in the complete response letter: the risk of infections related to intravenous infusion ports and renal toxicity.

Addressing the Narcolepsy Diagnosis Delay

August 20, 2019
  • Matt Hoffman

The director of the Sleep-Wake Disorders Center at Montefiore Medical Center will offer further insights on narcolepsy at the upcoming International Congress on the Future of Neurology, September 27-28, 2019 in New York City.

Case Report: Unusual New Onset Seizures

August 16, 2019
  • Uma Menon, MD, MBA

A generally healthy, young adult male presents with first generalized tonic-clonic seizure followed by episodes of violent psychosis.

Browse more articles

Resource Topics rightRail

  • Resource Topics
  • Partner Content
  • Headache and Migraine
  • Epilepsy
  • TBI
  • Epilepsy and Seizure
  • Alzheimer disease
There is currently no available content. Please check back soon.
Connect with Us
  • Column 1
    • Home
    • About Us
    • Contact Us
  • Column 2
    • Editorial Info
    • Editorial Board
  • Column 3
    • Advertising Info
    • Reprints
    • Advertising Terms
  • Column 4
    • Terms of Use
    • Privacy Policy
Modern Medicine Network
© UBM 2019, All rights reserved.
Reproduction in whole or in part is prohibited.

We've noticed that you're using an ad blocker

Our content is brought to you free of charge because of the support of our advertisers. To continue enjoying our content, please turn off your ad blocker.

It's off now Dismiss How do I disable my ad blocker?
❌

How to disable your ad blocker for our site:

Adblock / Adblock Plus
  • Click on the AdBlock / AdBlock Plus icon on the top right of your browser.
  • Click “Don’t run on pages on this domain.” OR “Enabled on this site.”
  • Close this help box and click "It's off now".
Firefox Tracking Prevention
  • If you are Private Browsing in Firefox, "Tracking Protection" may casue the adblock notice to show. It can be temporarily disabled by clicking the "shield" icon in the address bar.
  • Close this help box and click "It's off now".
Ghostery
  • Click the Ghostery icon on your browser.
  • In Ghostery versions < 6.0 click “Whitelist site.” in version 6.0 click “Trust site.”
  • Close this help box and click "It's off now".
uBlock / uBlock Origin
  • Click the uBlock / uBlock Origin icon on your browser.
  • Click the “power” button in the menu that appears to whitelist the current website
  • Close this help box and click "It's off now".